USPTO serial 79206566
MEDISTUS
Reviewed by CopyMark Law Group
Reg. 5393501Status 709
- Filing date
- Status date
- Registration date
- Feb 6, 2018
- Examiner
- HESIK, APRIL ANNE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MEDISTUS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Aldehydes for pharmaceutical purposes; Alginate dietary supplements; Aloe vera preparations for pharmaceutical purposes; Amino acids for medical purposes; Anti-oxidant food supplements; Antioxidants, namely, food supplements; Antibiotics; Antibiotics for human use; Mineral food supplements; Antioxidant pills, namely, food supplements; Mineral water salts for medical purposes; Mineral waters for medical purposes; Asthmatic tea; Bacteriological preparations for medical and veterinary use; Cultures of microorganisms for medical use; Cultures of microorganisms for veterinary use; Bacterial poisons; Bacterial preparations for medical and veterinary use; Medicinal ointments for the treatment of viral and bacterial infections; Balms for medical purposes; Balsamic preparations for medical purposes, namely balms for medical purposes; Biological tissue cultures for veterinary purposes; Biological preparations for medical purposes for the treatment of viral and bacterial infections; Biological preparations for veterinary purposes for the treatment of viral and bacterial infections; Biological tissue cultures for medical purposes; medicated skin care lotions; Skin care creams for medical use; Wheat germ dietary supplements; Melissa water for pharmaceutical purposes; Gallic acid for pharmaceutical purposes; Stick liquorice for pharmaceutical purposes; Fennel for medical purposes; Dietary fiber for constipation; Yeast for pharmaceutical purposes; Yeast dietary supplements; Yeast extracts for pharmaceutical purposes; Elixirs being pharmaceutical preparations for the treatment of viral and bacterial infections; Enzymes for medical purposes; Enzyme preparations for medical purposes; Tonics being medicines for the treatment of viral and bacterial infections; Enzyme dietary supplements; Eucalyptol for pharmaceutical purposes; Eucalyptus for pharmaceutical purposes; Sterilising preparations; Disinfectants other than disinfectant soap; Disinfectants and antiseptics; Germicides; disinfectants, other than disinfectant soap; Disinfectants for medical instruments; Fumigants; Glucose for medical purposes; By-products of the processing of cereals for medical purposes; Glucose dietary supplements; Glucose preparations for medical purposes; Fungicides; Fungicidal fungal agents; Medicinal tea; Medicinal herbs; Medicated candy; Extracts of medicinal herbs; Herbal teas for medicinal purposes; Herbal beverages for medicinal use; Medicinal herbal extracts for medical purposes; Drugs for medical purposes, namely, for the treatment of respiratory infections; Medicated lozenges; medicated dragees being medicated candy; Medicated food supplements; Herbal medicine; Extracts of medicinal plants; Pharmaceuticals and natural remedies for the treatment of respiratory infections; pharmaceutical compositions for the treatment of respiratory infections; pharmaceutical sweets; pharmaceuticals for the treatment of respiratory infections; smoking herbs for medical purposes; medicated food supplements for human consumption, food additives for medicinal purposes namely, gum arabic, tisanes being medicated herbal beverages; urinary tract disinfectants; Anti-uric preparations; vaginal washes for medical purposes; douching preparations for medical purposes; Irish moss for medical purposes; Iodine; Iodine for pharmaceutical purposes of disinfection; Iodides for pharmaceutical purposes of disinfection; Camphor oil for medical purposes; Camphor for medical purposes; Candy for medical purposes; Dill oil for medical purposes; Capsules sold empty for medicines; Parasiticides; Tissues impregnated with pharmaceutical lotions; Disinfectants impregnated into tissues; pre-moistened wipes for medical use; Ointments for pharmaceutical purposes for the treatment of viral and bacterial infections; Sulfur sticks being disinfectants; Flowers of sulfur for pharmaceutical purposes; Angostura bark for medical purposes; Mangrove bark for pharmaceutical purposes; Quebracho bark for medical use; Condurango bark for medical purposes; Croton bark for medical purposes; Collodion for pharmaceutical purposes; Extracts of hops for pharmaceutical purposes; Lupulin for pharmaceutical purposes; Air purifying preparations; disinfectant washes, other than soap, for hygenic purposes; Sterilizing washes for hygenic purposes; Royal jelly for pharmaceutical purposes; Royal jelly dietary supplements; Mint for pharmaceutical purposes; Menthol for pharmaceutical purposes; Preparations of microorganisms for medical or veterinary use, namely, cultures of microorganism; Mustard for pharmaceutical purposes, namely, mustard plasters; Mustard powder for medical purposes; Mustard oil for medical purposes; Mustard preparations for medical purposes, namely, mustard plasters; Medicinal roots; Pine barks for pharmaceutical purposes; Dietary supplements, namely, preparations of trace elements for human and animal use; Dietary supplements, namely, trace element preparations for human use; Cachets for pharmaceutical purposes, namely, gelatin capsules sold empty; Medicinal oils; Lozenges for pharmaceutical purposes; Cough pastilles for medical use; Pollen dietary supplements; Propolis for pharmaceutical purposes; Propolis dietary supplements; Chewing gum for medical purposes; Salts for medical purposes, namely, sodium salts for medical purposes; Medicated mouthwash; Mouthwashes for medical purposes; Mouthwashes being gargles for medical purposes; Medicated mouth spray; medicated dental rinse; medicated antiseptic mouthwashes; Medicated antimicrobial mouthwashes; medicated serums for the treatment of mouth and throat; Syrups for pharmaceutical purposes for mouth disinfection and the treatment of respiratory diseases; Tinctures for medical purposes for mouth disinfection and the treatment of respiratory diseases; Detergents for medical purposes; Vaccines; Vitamin tablets; Vitamin preparations; Vitamin supplements; Effervescent vitamin tablets; Mixed vitamin preparations; Gelatine for medical purposes, namely, empty capsules and gelatine gum pastilles; Fumigation preparations for medical purposes; gurjun, gurjon or gurjan balsam for medical purposes; Bronchodilating preparations | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Vitaplus Élelmiszer, Gyógyszergyártó és Kereskedelmi Korlátolt Felelosségu Társaság
- Other trademarks owned by Ceres Pharma Hungary Kft.
- Other trademarks owned by Vitaplus Élelmiszer, Gyógyszergyártó és Kereskedelmi Korlátolt Felelosségu Társaság
- Other trademarks owned by Vitaplus Élelmiszer, Gyógyszergyártó és Kereskedelmi Korlátolt Felelosségu Társaság
- Other trademarks in Class 005
- Similar marks named MEDISTUS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 23, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 22, 2025 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 3, 2025 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Aug 3, 2025 | INPC | INVALIDATION PROCESSED | — |
| Apr 23, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 8, 2025 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Aug 23, 2024 | C71T | CANCELLED SECTION 71 | — |
| Jul 20, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 16, 2018 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| May 16, 2018 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| May 6, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 6, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 21, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 1, 2017 | NPUB | NOTICE OF PUBLICATION | — |
| Oct 13, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 5, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 5, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 5, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 9, 2017 | RFNP | REFUSAL PROCESSED BY IB | — |
| May 23, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 23, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 14, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 13, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 9, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 5, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| May 5, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 4, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |